Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approaches

References

• Park NY, Lee JH, Kim MW, et al. Identification of the Vibrio vulnificus WbpP gene and evaluation of its role in virulence. Infect Immun 2006;74:721–8
   PubMed Web of Science ®Google Scholar
• Zuppardo AB, Siebeling RJ. An epimerase gene essential for capsule synthesis in Vibrio vulnificus. Infect Immun 1998;66:2601–6
   PubMed Web of Science ®Google Scholar
• Stelma GN, Jr Reyes AL, Peeler JT, et al. Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus. Appl Environ Microbiol 1992;58:2776–82
   PubMed Web of Science ®Google Scholar
• Chiang SR, Chuang YC. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 2003;36:81–8
   PubMedGoogle Scholar
• Linkous DA, Oliver JD. Pathogenesis of Vibrio vulnificus. FEMS Microbiol Lett 1999;174:207–1
   PubMed Web of Science ®Google Scholar
• Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun 2009;77:1723–33
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim MW, Kim BS, et al. Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol 2007;45:146–52
   PubMed Web of Science ®Google Scholar
• Chen CY, Wu KM, Chang YC, et al. Comparative genome analysis of Vibrio vulnificus, a marine pathogen. Genome Res 2003;13:2577–87
   PubMed Web of Science ®Google Scholar
• Gulig PA, Bourdage KL, Starks AM. Molecular pathogenesis of Vibrio vulnificus. J Microbiol 2005;43(Spec No):118–31
   PubMed Web of Science ®Google Scholar
• Koo BS, Lee JH, Kim SC, et al. Phospholipase A as a potent virulence factor of Vibrio vulnificus. Int J Mol Med 2007;20:913–18
   PubMed Web of Science ®Google Scholar
• Creuzenet C, Belanger M, Wakarchuk WW, et al. Expression, purification, and biochemical characterization of WbpP, a new UDP-GlcNAc C4 epimerase from Pseudomonas aeruginosa serotype O6. J Biol Chem 2000;275:19060–7
   PubMed Web of Science ®Google Scholar
• Valiente E, Jimenez N, Merino S, et al. Vibrio vulnificus biotype 2 serovar E gne but not galE is essential for lipopolysaccharide biosynthesis and virulence. Infect Immun 2008;76:1628–38
   PubMed Web of Science ®Google Scholar
• Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389–402
   PubMed Web of Science ®Google Scholar
• Messaoudi A, Belguith H, Ben Hamida J. Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase. Theor Biol Med Model 2013;10:22
   PubMed Web of Science ®Google Scholar
• Schwede T, Kopp J, Guex N, et al. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 2003;31:3381–5
   PubMed Web of Science ®Google Scholar
• Lambert C, Leonard N, De Bolle X, et al. ESyPred3D: prediction of proteins 3D structures. Bioinformatics 2002;18:1250–6
   PubMed Web of Science ®Google Scholar
• Laskowsky RA, MacArthur MW, Moss DS, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993;26:283–91
   Web of Science ®Google Scholar
• Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407–10
   PubMed Web of Science ®Google Scholar
• Shahlaei M, Madadkar-Sobhani A, Mahnam K, et al. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation. Biochim Biophys Acta 2011;1808:802–17
   PubMed Web of Science ®Google Scholar
• Ramatenki V, Potlapally SR, Dumpati RK, et al. Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer. J Recept Signal Transduct 2014;15:1–14
   Google Scholar
• Castrignano T, Meo DPD, Cozzetto D, et al. The PMDB protein model database. Nucleic Acids Res 2006;34:306–9
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Singh P, Singh SK. Molecular modeling studies and comparative analysis on structurally similar HTLV and HIV protease using HIV-PR inhibitors. J Recept Signal Transduct Res 2014;34:361–71
   PubMed Web of Science ®Google Scholar
• Du J, Sun H, Xi L, et al. Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation. J Comput Chem 2011;32:2800–9
   PubMed Web of Science ®Google Scholar
• Shaw DE. Desmond molecular dynamics system. Maestro-Desmond interoperability tools. Version 4.1. New York (NY): Schrödinger, LLC; 2015
   Google Scholar
• Sandeep S, Priyadarshini V, Pradhan D, et al. Docking and molecular dynamics simulations. studies of human protein kinase catalytic subunit alpha with antagonist. J Clin Sci Res 2012;1:15–23
   Google Scholar
• Lindin I, Wuxiuer Y, Kufareva I, et al. Homology modeling and ligand docking of Mitogen activated protein kinase-activated protein kinase 5 (MK5). Theor Biol Med Model 2013;10:56
   PubMed Web of Science ®Google Scholar
• SiteMap. Version 3.4. New York, NY: Schrödinger, LLC; 2015
   Google Scholar
• LigPrep. Version 3.3. New York, NY: Schrödinger, LLC; 2015
   Google Scholar
• QikProp. Version 4.3. New York, NY: Schrödinger, LLC; 2015
   Google Scholar
• Gade DR, Kunala P, Raavi D, et al. Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives. J Recept Signal Transduct Res 2015;35:189–201
   PubMed Web of Science ®Google Scholar
• Sengupta D, Verma D, Naik PK. Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: screening using molecular mechanics generalized born/surface area and absorption, distribution, metabolism and excretion properties. H Biosci 2007;32:1307–16
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility andpermeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3–25
   Web of Science ®Google Scholar
• Chandra N, Bhagavat R, Sharma E, et al. Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy. J Clin Bioinformatics 2011;1:5
   PubMedGoogle Scholar
• Kirubakaran P, Karthikeyan M, Singh KD, et al. In silico structural and functional analysis of the human TOPK protein by structure modeling and molecular dynamics studies. J Mol Model 2013;19:407–19
   PubMed Web of Science ®Google Scholar
• Dhanachandra Singh KH, Kirubakaran P, Manikandaprabhu S, et al. Docking Studies of Adenosine Analogues with NS5 Methyltransferase of Yellow Fever Virus. Indian J Microbiol 2012;52:28–34
   PubMed Web of Science ®Google Scholar
• Glide. Version 6.6. New York, NY: Schrödinger, LLC; 2015
   Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al.. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49
   PubMed Web of Science ®Google Scholar
• Guttikonda V, Raavi D, Maadwar SK, et al. Molecular insights of benzodipyrozole as CDK2 inhibitors: combined molecular docking, molecular dynamics, and 3D QSAR studies. J Recept Signal Transduct Res 2015;22:1–11
   Google Scholar
• Induced Fit Docking protocol 2015-1. Glide Version 6.4. Prime Version 3.7. New York (NY): Schrödinger, LLC; 2015
   Google Scholar
• Sherman W, Day T, Jacobson MP, et al. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 2006;49:534–53
   PubMed Web of Science ®Google Scholar
• Gouet P, Robert X, Courcelle E. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res 2003;31:3320–3
   PubMed Web of Science ®Google Scholar
• Wang YT, Chan CH, Su ZY, et al. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase. Biophys Chem 2010;147:74–80
   PubMed Web of Science ®Google Scholar
• Kondagari B, Dulapalli R, Krishna Murthy D, et al. Towards the virtual screening of BIK inhibitors with the homology-modeled protein structure. Med Chem Res 2013;22:1184–96
   Web of Science ®Google Scholar
• Singh R, Balupuri A, Elizabeth Sobhia M. Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases. Mol Simulation 2013;39:49–58
   Web of Science ®Google Scholar